Physician profile
Chris B Winter
NPI 1871555102
$14,676.52
in general payments reported to CMS, 2019-2025
14 companies · $2,402 in 2025
The $2,402 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,021 · 2020: $159 · 2021: $165 · 2023: $441 · 2024: $5,489 · 2025: $2,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,020 · Food and Beverage: $1,386 · Travel and Lodging: $740 · Gift: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,020.00 |
| Food and Beverage | $1,385.66 |
| Travel and Lodging | $740.38 |
| Gift | $185.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,245.68 | 2019-2025 | Da Vinci Surgical System |
| Stryker Corporation | $970.07 | 2019-2023 | 1688 |
| Medical Device Business Services, INC. | $189.84 | 2021-2025 | Echelon Flex |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Becton, Dickinson and Company | $26.62 | 2025 | |
| Covidien LP | $24.81 | 2019 | |
| Medtronic, INC. | $22.81 | 2024 | Reliatack |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Octapharma USA, INC. | $19.91 | 2025 | Fibryga |
| Teleflex LLC | $18.89 | 2023 | Deknatel |
| Acell, INC. | $14.08 | 2020 | |
| Depuy Synthes Sales INC. | $13.51 | 2023 | Matrixrib |
| Innocoll Pharmaceuticals Limited | $13.09 | 2021 | |
| Z-Medica, LLC | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.